Six-Peat: CTL Amedica's Sean Suh Recognized as a Top Spine Inventor

For the sixth year in a row, CTL Amedica CTO Sean Suh has been included in the Spinemarket Inc. Patent Analysis and Power Index, having been named to the current Top Twenty+ Inventors in Spine list. Suh has been included on the list every year, since its 2016 inception. This year, Suh is ranked number 13 on the list, with nine patents filed/cited in 2021 and 83 total from 2016-2021.

1upHealth Selected by NCQA As Partner in Digital Quality Solutions Pilot

MULTI-LEVEL, CLIA COMPLIANT CLINICAL REFERENCE MATERIALS FOR MICROPROTEIN TESTING AVAILABLE FROM VERICHEM LABORATORIES

Liquid stable and ready-to-use clinical reference materials for Microprotein testing are now available from VERICHEM LABORATORIES.

Patient centricity in drug innovation and packaging design to take centre stage at Connect in Pharma in Geneva this September

Connect in Pharma will highlight opportunities for the biopharmaceutical sector to reinvent packaging to be more focussed on patient needs. Oral medications are particularly ripe for a rethink, says speaker Tiffany McIntire, a Principal Systems Engineer at Roche.

Birmingham Biotech and Tanner Pharma Group enter distribution partnership for innovative nasal spray in Latin America

Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and TannerLAC UK Limited ("TannerLAC"), a part of Tanner Pharma Group, have entered into a license agreement for the distribution of Norizite™ Nasal Spray in Latin America. TannerLAC provides pharmaceutical, biotech, and healthcare companies with a single-point partner for the commercialization of their products in challenging international markets.

CD Formulation Launches API Chemical Modification Services to Address Drug Solubility, Bioavailability, and Dissolution Rate Issues

Having abundant expertise in drug formulation and pharmaceutical preparation, the New York-based CRO company CD Formulation recently announces that it is now capable of conducting a wide range of API chemical modification services, including pH modification drug molecular service, drug salt formation service, drug pegylation service, and different groups of precursor drug design service, to help researchers address some of the long-standing issues in drug development like drug solubility, bioavailability, and dissolution rate.

The Healthcare Technology Report Names Andrea Kowalski on List of Top 25 Women in Healthcare IT in 2022

The Healthcare Technology Report has officially named Tebra’s Senior Vice-President of Product, Andrea Kowalski, to its list of Top 25 Women in Healthcare IT in 2022.

Lyniate Launches New Cloud Deployment Option for Market Leading Corepoint Integration Engine Company also Receives ISO 27001 Information Security Certification for all Products

BOC Sciences: A Robust Isotope Labeling Service Vendor

BOC Sciences offers professional stable isotope labeling services to support worldwide partners from preclinical to commercial stages.

Complete Virtual Screening Solutions at BOC Sciences to Unleash Novel Drug Discovery Potential

Today, BOC Sciences released a complete set of virtual screening solutions to help partners maximize the diversity of hits using its ultra-large-scale purchasable compound libraries.

BOC Sciences Unveils Access to Comprehensive Set of PROTAC In Vitro Evaluation Services

BOC Sciences today unveiled access to its comprehensive set of PROTAC in vitro evaluation services for biopharmaceutical clients and partners to expedite their PROTAC development from preclinical studies to clinical trials.

Creative Peptides Unveils Product Portfolio of Standard Fmoc/Boc-PNA Monomers

Creative Peptides supplies standard Fmoc- and Boc-PNA monomers that can be ordered in large quantities with high purity, solubility, and reactivity.

Alfa Chemistry Catalysts Releases Asymmetric Organocatalysts for Chemical Reactions

As a reliable source for versatile catalysts, Alfa Chemistry Catalysts today announces that it has launched a rich of collection of asymmetric organocatalysts, including chiral amines, chiral amino acids, chiral ammonium salts, chiral bicyclic guanidines, chiral diols, chiral imidazolidinones, chiral isothioureas, chiral n-heterocyclic carbenes (NHC), chiral oxazaborolidines, chiral sulfonic acids, cinchona alkaloids, and prolines, proline analogs. All can be used to accelerate different types of chemical reactions for research and production, whereas all are of high purity and of high-popularity among consumers.

MicrobioSeq Releases Nanopore-Based Microbial Epigenomics Solutions to Accelerate Your Research

CD Genomics Supercharges Transcriptomics Research by Digital RNA Sequencing Technology

uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management

uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management LONDON and NEW YORK, May 25, 2022-- uMotif today announced a new investment of $25.5m from a fund managed by Athyrium Capital Management, LP, the New York-based investment firm. The new funding will support continued scale up of uMotif's unique patient-first software platform for clinical research.

CD BioSciences Introduces Comprehensive Solutions for GPCR Expression

CD BioSciences introduces comprehensive solutions for GPCR expression based on various strategies and technique platforms to facilitate customers’ cutting-edge programs.

STEMart Introduces Biocompatibility Evaluation of Breathing Gas Pathways in Medical Devices

STEMart expands its Biocompatibility Testing services and introduces biocompatibility evaluation of breathing gas pathways in medical devices.

Amerigo Scientific Supports Microbiology Research with the Launch of HHD BROTH

Amerigo Scientific now introduces HHD Broth to the life science research community.

Creative Diagnostics Launches Antibody-dependent Enhancement Assay Services

Creative Diagnostics recently introduces comprehensive services for antibody-dependent enhancement (ADE) assay.